You have 9 free searches left this month | for more free features.

patients with stable drug substitution therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Drug Resistant Epilepsy Trial in Jakarta Pusat, Jakarta (Valproic acid, Carbamazepin, Phenytoin)

Recruiting
  • Drug Resistant Epilepsy
  • Valproic acid
  • +5 more
  • Jakarta Pusat, Jakarta, Indonesia
  • +2 more
Jan 14, 2023

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Completed
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    Quest Clinical Research
Sep 28, 2021

Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce

Active, not recruiting
  • HCV
  • +2 more
  • Evaluate model of care for HCV-infected adults with on-going opioid misuse
  • Washington, District of Columbia
  • +1 more
Feb 2, 2022

Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

Not yet recruiting
  • Human Immuno-deficiency Virus (HIV) Disease
  • (no location specified)
Sep 5, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023

HIV-1-infection Trial in Moscow, Saint-Petersburg (VM-1500A-LAI, ELPIDA®)

Completed
  • HIV-1-infection
  • Moscow, Russian Federation
  • +1 more
Jan 10, 2022

Opioid Use Disorder, Moderate Trial in Berlin, New York (Levomethadone HCl, Methadone, Morphine Sulfate)

Recruiting
  • Opioid Use Disorder, Moderate
  • Levomethadone HCl
  • +4 more
  • Berlin, New Jersey
  • +1 more
Mar 16, 2022

Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,

Completed
  • Stable Angina
  • +2 more
  • 3-months DAPT
  • 1-year DAPT
  • Busan, Korea, Republic of
  • +11 more
Jan 8, 2023

Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents Trial in Beijing, Xuzhou, Chengdu (CYP2C19 genotype testing)

Recruiting
  • Angina, Stable
  • +3 more
  • CYP2C19 genotype testing
  • Beijing, Beijing, China
  • +11 more
Nov 4, 2021

Central Diabetes Insipidus (cDI) Trial in Basel (Intranasal OXT, Placebo nasal spray)

Not yet recruiting
  • Central Diabetes Insipidus (cDI)
  • Intranasal OXT
  • Placebo nasal spray
  • Basel, Switzerland
    University Hospital Basel, Department of Endocrinology, Diabetes
Sep 6, 2023

Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

Not yet recruiting
  • Diabetes Mellitus Type 2 With Proteinuria
  • +12 more
  • Empagliflozin 10 MG
  • +6 more
  • (no location specified)
Oct 17, 2023

Atrial Fibrillation, HFpEF - Heart Failure With Preserved Ejection Fraction Trial (Radiofrequency catheter ablation (RFCA),

Not yet recruiting
  • Atrial Fibrillation
  • HFpEF - Heart Failure With Preserved Ejection Fraction
  • Radiofrequency catheter ablation (RFCA)
  • Medical Therapy
  • (no location specified)
Nov 5, 2023

Hepatitis C Trial in Melbourne, Dundee, Cardiff (Reach Pathway, Education-only Pathway)

Completed
  • Hepatitis C
  • Reach Pathway
  • Education-only Pathway
  • Melbourne, Australia
  • +2 more
Oct 12, 2021

CD20+ Aggressive B-Cell Lymphoma Trial in Germany (Conventional Vincristine, Liposomal Vincristine, Ricover-scheme rituximab)

Active, not recruiting
  • CD20+ Aggressive B-Cell Lymphoma
  • Conventional Vincristine
  • +3 more
  • Homburg, Saarland, Germany
  • +125 more
Nov 11, 2022

Hypercholesterolemia, Atherosclerotic Ischemic Disease Trial in Heidelberg, London (lerodalcibep, Inclisiran)

Enrolling by invitation
  • Hypercholesterolemia
  • Atherosclerotic Ischemic Disease
  • Nantes, Cedex 01, France
  • +6 more
Nov 3, 2022

Substance Use Disorders, Prenatal Care, Pregnancy Outcome Trial in Hamilton (Monthly Pregnancy Screening, Usual Care)

Terminated
  • Substance Use Disorders
  • +2 more
  • Monthly Pregnancy Screening
  • Usual Care
  • Hamilton, Ontario, Canada
    The Hamilton Clinic
Apr 12, 2022

Graves Disease, Relapse, Treatment Trial in Nanjing (Methimazole)

Recruiting
  • Graves Disease
  • +3 more
  • Nanjing, China
    the First Affiliated Hospital of Nanjing Medical University
Jul 21, 2022

Hepatitis C Trial in Australia (Campaign days)

Recruiting
  • Hepatitis C
  • Campaign days
  • Campbelltown, New South Wales, Australia
  • +7 more
Mar 30, 2022

Adrenal Insufficiency Trial in Tunis (Hydrocortisone (capsule))

Completed
  • Adrenal Insufficiency
  • Hydrocortisone (capsule)
  • Tunis, Tunisia
  • +1 more
Jul 11, 2022

Cardiovascular Diseases, Hyper-LDL-cholesterolemia Trial in Cincinnati (lerodalcibep)

Active, not recruiting
  • Cardiovascular Diseases
  • Hyper-LDL-cholesterolemia
  • Cincinnati, Ohio
  • +2 more
Nov 3, 2022

Evaluating the Chain of Addiction Care (CAC)

Recruiting
  • Hepatitis C, Chronic
  • Substance Use Disorders
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    May 31, 2022

    Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Stroke Trial in India, Israel, United States (lerodalcibep,

    Active, not recruiting
    • Cardiovascular Risk Factor
    • +3 more
    • Cincinnati, Ohio
    • +5 more
    Nov 3, 2022

    Heterozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep)

    Active, not recruiting
    • Heterozygous Familial Hypercholesterolemia
    • Cincinnati, Ohio
    • +6 more
    Nov 3, 2022

    Coronary Artery Disease, Prediabetic State Trial in Seoul (Dapagliflozin 10mg, Lifestyle modification)

    Terminated
    • Coronary Artery Disease
    • Prediabetic State
    • Dapagliflozin 10mg
    • Lifestyle modification
    • Seoul, Korea, Republic of
      Asan Medical Center
    Sep 21, 2022

    Hepatitis C Trial in Darlinghurst, Kingswood, Newcastle (Grazoprevir/elbasvir)

    Terminated
    • Hepatitis C
    • Darlinghurst, New South Wales, Australia
    • +4 more
    Feb 21, 2020